• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • Guideline and Standard Update for Medical Devices & IVDs in January and February 2021

Guideline and Standard Update for Medical Devices & IVDs in January and February 2021

Friday, 26 February 2021 / Published in Medical Device, News, NMPA Registration in China

Guideline and Standard Update for Medical Devices & IVDs in January and February 2021

China Regulatory Guidelines Issued / Updated

The NMPA (National Medical Products Administration) issued regulatory guidelines for 5 medical devices (including IVDs) throughout January and February 2021:

  • Technical Guidelines for Clinical Evaluation on Medical Magnetic Resonance Imaging System  (2020 amended version)
  • Technical Guideline for Clinical Evaluation on Ultrasonic Imaging and Diagnostic Devices
  • Technical Guideline for Clinical Evaluation on X-ray Computed Tomography Equipment
  • Technical Guideline for Mycoplasma Pneumoniae IgM/IgG Antibody Test Reagents
  • Technical Guideline for Cryptococcus Capsular Polysaccharide Antigen Test Reagents
  • Technical Guideline for Gene Mutation Reagents for Genetic Deafness

The NIFDC announced to solicit public comments for the implementation of GB and YY standards for the following 4 medical electrical equipment in January and February 2021:

  • YY/T standard to replace YY 91064-1999 for Dental rotary instruments-Drill used in Dental Implant Placement and Treatment
  • GB standard for medical electrical equipment – Part 2-71: Particular requirements for the basic safety and essential performance of functional near-infrared spectroscopy (NIRS) equipment
  • GB standard for medical electrical equipment – Part 2-75: Particular requirements for the basic safety and essential performance of photodynamic therapy and photodynamic diagnosis equipment
  • GB standard for medical electrical equipment – Part 2-55: Particular requirements for the basic safety and essential performance of respiratory gas monitors

Fast-Track Approval Updates

The NMPA granted the fast-track approval for the product registration of Lifetech Scientific’s iliac artery bifurcation stent system and Hunan Apt Med’s anchor balloon catheter via the Procedure for Prioritized Review and Approval of Medical Devices.

The NMPA also approved the application of the following products to enter the fast-track approval pathway. All the manufacturers are Chinese companies.

Fast-Track Approval PathwayProductManufacturer
Prioritized Review and Approval of Medical DevicesPhotosensitive zirconia ceramic material for dental crownKunshan Porimy
Prioritized Review and Approval of Medical DevicesMeasurement Software for Quantitative Intravascular Fractional FlowPulse Medical Imaging Technology (Shanghai) CO.LTD
Special Review Procedure for Innovative Medical DevicesMagnetic Resonance Imaging SystemXingaoyi Medical Equipment Co.,Ltd.
Special Review Procedure for Innovative Medical DevicesElectronic endoscopic image aided diagnostic software for lower digestive tract polypsWuHan EndoAngel Medical Technology Co.,LTD
Special Review Procedure for Innovative Medical DevicesProton Therapy SystemShanghai APACTRON Particle Equipment Co., Ltd
Special Review Procedure for Innovative Medical DevicesModule Embedded Aortic Arch Covered Stent SystemDINOVA Med-Hangzhou Weiqiang
Special Review Procedure for Innovative Medical DevicesAortic Covered Stent SystemLifetech Scientific


By Jacky Li. Contact Cisema if you would like to learn more.

What you can read next

China cosmetics filing FAQs
China cosmetics filing FAQs – November and December 2022
China drug real-world study design
China drug real-world study design and protocol framework guidelines is open for comments
China Regulatory Round-up for Health Food from November 2020 to January 2021

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • Submission of safety information for cosmetics ingredients

    Submission of safety information for cosmetics raw materials – Draft guidelines issued

    Submission of safety information for cosmetics ...
  • avoid animal testing in Chinaweb-2023

    How to avoid animal testing in China for cosmetics | Cisema Webinar

    China’s beauty and cosmetic market has be...
  • guidelines for medical devices registration

    Guidelines for medical devices registration in China – New development plans in 2023

    Guidelines for medical devices registration in ...
  • China DMF of API

    China DMF of API, Excipient & Packaging Materials: Market & Regulatory | Cisema Webinar

    “China DMF of API, Excipient & Packag...
  • pre-phase III drug clinical trial meeting guidelines

    Pre-phase III drug clinical trial meeting guidelines released

    Pre-phase III drug clinical trial meeting guide...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP